Pub Date : 2020-05-01DOI: 10.1891/9780826174116.0007
A. R. Finestein
{"title":"On the coordination of care.","authors":"A. R. Finestein","doi":"10.1891/9780826174116.0007","DOIUrl":"https://doi.org/10.1891/9780826174116.0007","url":null,"abstract":"","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"4 1","pages":"813-4"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81012103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Polyuria.","authors":"H. D. de Wardener","doi":"10.32388/ggug3y","DOIUrl":"https://doi.org/10.32388/ggug3y","url":null,"abstract":"","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"285 1","pages":"199-212"},"PeriodicalIF":0.0,"publicationDate":"2020-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80263255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2008-01-01DOI: 10.1016/S1873-9954(08)70105-8
R. D'Incà, M. Paccagnella, R. Cardin, S. Voltan, V. Baldo, G. Sturniolo
{"title":"Which 5-ASA? Variation in colonic mucosal concentration of different pharmaceutical mesalamine formulations","authors":"R. D'Incà, M. Paccagnella, R. Cardin, S. Voltan, V. Baldo, G. Sturniolo","doi":"10.1016/S1873-9954(08)70105-8","DOIUrl":"https://doi.org/10.1016/S1873-9954(08)70105-8","url":null,"abstract":"","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"21 1","pages":"206-206"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87809393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1987-01-01DOI: 10.1016/0021-9681(87)90132-9
Dennis Gray , Douglas MacAdam , Duncan Boldy
A comparison is made between the expenditure during the last 90 days of life on 98 terminal cancer patients cared for by a home based hospice service and that on matched patients dying without the home hospice service. The control patients were matched for site of primary cancer, age and sex. The individual records of both groups of patients were analyzed and costed. It was found that the costs of providing 24 hour comprehensive medical and nursing care at home to those dying of cancer and support for their families was no more expensive than traditional institutional care.
{"title":"A comparative cost analysis of terminal cancer care in home hospice patients and controls","authors":"Dennis Gray , Douglas MacAdam , Duncan Boldy","doi":"10.1016/0021-9681(87)90132-9","DOIUrl":"10.1016/0021-9681(87)90132-9","url":null,"abstract":"<div><p>A comparison is made between the expenditure during the last 90 days of life on 98 terminal cancer patients cared for by a home based hospice service and that on matched patients dying without the home hospice service. The control patients were matched for site of primary cancer, age and sex. The individual records of both groups of patients were analyzed and costed. It was found that the costs of providing 24 hour comprehensive medical and nursing care at home to those dying of cancer and support for their families was no more expensive than traditional institutional care.</p></div>","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"40 8","pages":"Pages 801-810"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0021-9681(87)90132-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14242549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1987-01-01DOI: 10.1016/0021-9681(87)90017-8
Matthew H. Liang, Celeste Robb-Nicholson
Questionnaires for measuring function, health status, and quality of life have been developed for the rheumatic and musculoskeletal disorders. These new measures are as valid and as reliable as traditional measures of clinical status in clinical trials and health services research and add a valuable dimension to outcome assessment. However, they have limitations for use in patient care. Questionnaires cannot determine the etiologic basis of functional disability; nor cover any one function in enough depth; nor deal with the relative nature of function; nor account for the differences in functional priorities. Questionnaires are statistical approaches and based on normative model; patient care is humanistic emphasizing differences. Nevertheless, the interaction between psychometric approaches and concerns of patient care is a necessary and desirable goal for all we seek to accomplish with clinical investigation.
{"title":"Health status and utility measurement viewed from the right brain: Experience from the rheumatic diseases","authors":"Matthew H. Liang, Celeste Robb-Nicholson","doi":"10.1016/0021-9681(87)90017-8","DOIUrl":"10.1016/0021-9681(87)90017-8","url":null,"abstract":"<div><p>Questionnaires for measuring function, health status, and quality of life have been developed for the rheumatic and musculoskeletal disorders. These new measures are as valid and as reliable as traditional measures of clinical status in clinical trials and health services research and add a valuable dimension to outcome assessment. However, they have limitations for use in patient care. Questionnaires cannot determine the etiologic basis of functional disability; nor cover any one function in enough depth; nor deal with the relative nature of function; nor account for the differences in functional priorities. Questionnaires are statistical approaches and based on normative model; patient care is humanistic emphasizing differences. Nevertheless, the interaction between psychometric approaches and concerns of patient care is a necessary and desirable goal for all we seek to accomplish with clinical investigation.</p></div>","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"40 6","pages":"Pages 579-583"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0021-9681(87)90017-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14426767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1987-01-01DOI: 10.1016/0021-9681(87)90098-1
Robert W. Peters , Robert Byington , Daniel Arensberg , Lawrence M. Friedman , Donald W. Romhilt , Allan Barker , Charles Laubach , Gary W. Wilner , Sidney Goldstein
In the Beta Blocker Heart Attack Trial, a double blind, randomized, controlled study, patients taking propranolol (180 or 240 mg/day) initiated 5–21 days post myocardial infarction had 26% fewer deaths than those taking placebo over a 25 month (mean) followup. Detailed analysis of the circumstances surrounding the BHAT deaths failed to reveal any striking difference between propranolol and placebo in the type of clinical event preceding death, the incidence and type of acute and prodromal signs and symptoms, the location of death, the activity preceding death or the percentage of deaths that were sudden or instantaneous, suggesting that propranolol may exert an “across the board” effect and improve survival by a combination of mechanisms. An unexpected finding was that the protective effect of propranolol appeared to occur during the hours of 10 p.m. to 7 a.m.
{"title":"Mortality in the beta blocker heart attack trial: Circumstances surrounding death","authors":"Robert W. Peters , Robert Byington , Daniel Arensberg , Lawrence M. Friedman , Donald W. Romhilt , Allan Barker , Charles Laubach , Gary W. Wilner , Sidney Goldstein","doi":"10.1016/0021-9681(87)90098-1","DOIUrl":"10.1016/0021-9681(87)90098-1","url":null,"abstract":"<div><p>In the Beta Blocker Heart Attack Trial, a double blind, randomized, controlled study, patients taking propranolol (180 or 240 mg/day) initiated 5–21 days post myocardial infarction had 26% fewer deaths than those taking placebo over a 25 month (mean) followup. Detailed analysis of the circumstances surrounding the BHAT deaths failed to reveal any striking difference between propranolol and placebo in the type of clinical event preceding death, the incidence and type of acute and prodromal signs and symptoms, the location of death, the activity preceding death or the percentage of deaths that were sudden or instantaneous, suggesting that propranolol may exert an “across the board” effect and improve survival by a combination of mechanisms. An unexpected finding was that the protective effect of propranolol appeared to occur during the hours of 10 p.m. to 7 a.m.</p></div>","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"40 1","pages":"Pages 75-82"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0021-9681(87)90098-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14665762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1987-01-01DOI: 10.1016/0021-9681(87)90110-X
T. Gregory Hislop , Nancy E. Waxler , Andrew J. Coldman , J. Mark Elwood , Lisa Kan
One hundred and thirty three recently diagnosed breast cancer patients completed a self-administered questionnaire which measured 16 psychosocial variables. After 4 years, three variables (expressive activities at home, extroversion, low anger) were significant prognostic factors for overall survival independent of clinical and other psychosocial factors; likewise three variables (expressive activities at home, expressive activities away from home, low cognitive disturbance) were significant independent prognostic factors for disease-free survival. These findings support the prognostic importance of the social emotional network.
{"title":"The prognostic significance of psychosocial factors in women with breast cancer","authors":"T. Gregory Hislop , Nancy E. Waxler , Andrew J. Coldman , J. Mark Elwood , Lisa Kan","doi":"10.1016/0021-9681(87)90110-X","DOIUrl":"10.1016/0021-9681(87)90110-X","url":null,"abstract":"<div><p>One hundred and thirty three recently diagnosed breast cancer patients completed a self-administered questionnaire which measured 16 psychosocial variables. After 4 years, three variables (expressive activities at home, extroversion, low anger) were significant prognostic factors for overall survival independent of clinical and other psychosocial factors; likewise three variables (expressive activities at home, expressive activities away from home, low cognitive disturbance) were significant independent prognostic factors for disease-free survival. These findings support the prognostic importance of the social emotional network.</p></div>","PeriodicalId":15427,"journal":{"name":"Journal of chronic diseases","volume":"40 7","pages":"Pages 729-735"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0021-9681(87)90110-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14718839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号